NDC 0378-0197-05
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-0197
- Requested NDC
- 0378-0197-05
- Package NDCs from labels
- 0378-0197-05
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-0197-01 | EA - Each | 0378-0197 | 705c1658-2999-4e88-b00b-270645844035 | 1 | 2012-07-24 |
| 0378-0197-05 | EA - Each | 0378-0197 | 4ae28794-a74e-4ae7-bbf0-2fa45be72791 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Chlordiazepoxide and Amitriptyline Hydrochloride | CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 66a756f2-ac77-451c-a19a-08896d73b15c | 2026-03-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Albuterol | ALBUTEROL | Mylan Pharmaceuticals Inc. | 9e6e982b-7dfe-45b8-aa76-754e8d2a8ef6 | 2026-03-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Spironolactone | SPIRONOLACTONE | Mylan Pharmaceuticals Inc. | beaf74db-4159-3b59-ef99-575c3ac99aa1 | 2026-03-12 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | 0c8c973f-13a2-4883-8316-4006398e2931 | 2026-03-11 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Mylan Pharmaceuticals Inc. | 83bcc2fb-6fb0-4f0e-8e66-592d327684ec | 2026-02-23 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Valacyclovir Hydrochloride | VALACYCLOVIR | Mylan Pharmaceuticals Inc. | 56bf715d-8280-4557-9f98-9693932199e5 | 2026-02-16 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Voriconazole | VORICONAZOLE | Mylan Pharmaceuticals Inc. | 67c174da-41b8-4738-8a22-dd814b8e96b8 | 2026-02-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Atenolol | ATENOLOL | Mylan Pharmaceuticals Inc. | a7048c81-6769-436b-8397-fbaa7489fcdf | 2026-02-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Estradiol | ESTRADIOL | Mylan Pharmaceuticals Inc. | 98770987-b313-4f2a-9aac-db0ab2068cc6 | 2026-02-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Paroxetine | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | Mylan Pharmaceuticals Inc. | 89dd7e24-85fc-4152-89ea-47ec2b48a1ed | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Albuterol Sulfate | ALBUTEROL SULFATE | Mylan Pharmaceuticals Inc. | 5329614f-ae0b-4854-bb6f-ea0b7dae87c0 | 2026-02-10 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Mylan Pharmaceuticals Inc. | 557d8d4d-8751-431c-b18e-9d5cf23fc579 | 2026-01-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Propranolol Hydrochloride | PROPRANOLOL HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | b94dcec7-7633-4a33-9cea-48161adeaf93 | 2026-01-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Travoprost Ophthalmic Solution, 0.004% | TRAVOPROST OPHTHALMIC SOLUTION, 0.004% | Mylan Pharmaceuticals Inc. | 00dc284f-fd96-423b-bb8f-b90ee13439bf | 2026-01-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| SILVER SULFADIAZINE | SILVER SULFADIAZINE | Mylan Pharmaceuticals Inc. | 7a6a9590-9983-46ff-ae5c-fe95f4e16cb8 | 2025-12-26 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| EXEMESTANE | EXEMESTANE | Mylan Pharmaceuticals Inc. | 69abd0ff-b200-4d1a-b14a-80e980a8e781 | 2025-12-24 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| FENTANYL | FENTANYL | Mylan Pharmaceuticals Inc. | 2a2238e9-4b5d-c56d-8663-dd354ff9ae0c | 2025-12-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| clindamycin phosphate | CLINDAMYCIN PHOSPHATE | Mylan Pharmaceuticals Inc. | f7480256-8b32-419a-8983-e2c413040dba | 2025-12-12 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Ambrisentan | AMBRISENTAN | Mylan Pharmaceuticals Inc. | 8080b009-361b-4505-b09a-0d91a0e4a2c0 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Diltiazem Hydrochloride | DILTIAZEM HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | ec7e93b8-666c-4d2f-8d08-07931e09f748 | 2025-11-27 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.